Malaysia Allergy Therapeutics Market Report 2022 to 2030

Malaysia Allergy Therapeutics Market Analysis

$ 3999

Malaysia Allergy Therapeutics Market was valued at $37 Mn in 2022 and is estimated to reach $62 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increased incidence of allergic illnesses and associated health issues is driving the need for allergy therapy medications. The major pharmaceutical players that are presently functioning in the market are GlaxoSmithKline, Sanofi, Novartis, Bayer, AstraZeneca, Eisai Co., Takeda Pharmaceutical Company, Pharmaniaga Berhad, Duopharma Biotech Bhd and Reckitt Benckiser.

ID: IN10MYPH429 CATEGORY: Pharmaceuticals GEOGRAPHY: Malaysia AUTHOR: Medha Sansanwal

Buy Now

Malaysia Allergy Therapeutics Market Executive Summary

Malaysia Allergy Therapeutics Market was valued at $37 Mn in 2022 and is estimated to reach $62 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period.

Allergies are immune responses that are periodically triggered by environmental chemicals known as allergens. Dust mites, pollen, mildew, and specific foods like milk, eggs, soy, and almonds are examples of common allergies. Allergy reactions can manifest in a variety of ways, ranging from mild symptoms like a runny nose and itchy eyes to more serious ones like anaphylaxis, which can cause unconsciousness and breathing problems. A few potential treatment options include immunotherapy, avoiding allergens, and prescription medications such as antihistamines and nasal corticosteroids.

Allergies may affect as much as 20% of the population in Malaysia overall. With prevalence rates ranging from 8.14% to 24% across multiple studies, allergic rhinitis is the most often reported allergy, affecting a substantial fraction of the population. With a prevalence of about 7% in preschoolers, food allergies are becoming more and more recognized, especially in youngsters. Additionally, skin allergies such as eczema are frequent in youngsters, with estimates ranging from 8% to 13%. In recent years, there has been a noticeable increase in the incidence of allergies across the nation, especially allergic rhinitis. Urbanization, shifting lifestyles, increased exposure to allergens such as dust mites and air pollution, and changes in the microbiome and immune system are some of the reasons for this increase.

Innovative allergy treatment solutions are becoming increasingly important in Malaysia's biotech industry, with developing firms spearheading this creative movement. As an innovative approach to allergy management, Biogenesys is noteworthy for its commitment to advancing allergen desensitization therapy through allergen modification. Pharmaniaga Life Sciences is also at the forefront of research, exploring the possibility of using natural products, specifically, palm oil derivatives, as a cutting-edge treatment for allergies.

Market Dynamics

Market Growth Drivers

Advancements in Allergen Immunotherapy (AIT): Sublingual immunotherapy (SLIT) patches and pills are examples of innovative replacements that have been developed, and they may provide longer-lasting relief with fewer side effects. This creates new business opportunities for these cutting-edge treatments.

Prevalence of Allergies: The rising incidence of respiratory allergies and other allergic illnesses, such as hay fever, is creating a need for effective allergy therapy drugs. Urbanization, changes in lifestyle, and environmental factors may all contribute to an increase in the prevalence of allergies.

Increased Awareness and Diagnosis: More access to healthcare, public health campaigns, and educational programs result in earlier and more accurate allergy diagnoses, which encourage people to seek treatment.

Market Restraints

High Cost of Treatment: The cost of allergy treatment can be very prohibitive for some people, particularly when it comes to AIT procedures like immunotherapy injections and SLIT tablets. The high price of allergy medications may prevent them from being widely used and made accessible, which would limit their market penetration.

Treatment Compliance and Adherence: Consistent commitment to long-term regimens is crucial for the efficacy of allergy treatments, especially immunotherapy therapies. Obstacles, including exorbitant expenses, complexity, or unfavourable outcomes resulting in insufficient patient compliance, possess the capacity to reduce therapy effectiveness and hinder the market's growth.

Awareness and Education: A lot of individuals are ignorant of the various kinds of allergies, the ways in which they can be treated, and the long-term advantages of controlling chronic allergies. Underdiagnosis, undertreatment, and dependence on ineffective over-the-counter drugs can result from this. This could impede the expansion of the market.

Healthcare Policies and Regulatory Landscape

The National Pharmaceutical Regulatory Agency (NPRA) and the Ministry of Health's Pharmaceutical Services Division (PSD) are essential to controlling the pharmaceutical industry, managing drug registration, and guaranteeing that allergy treatment medications meet safety and effectiveness requirements. Clinical trial facilitation and regulation are handled by the Malaysian Clinical Research Centre (CRC), while pharmaceutical product registration is approved and overseen by the Drug Control Authority (DCA). In addition, the Pharmacy Enforcement Division (PED) upholds pharmaceutical regulations, and the National Pharmaceutical Regulatory Division (NPRA) evaluates risk-benefit profiles.

Competitive Landscape

Key Players

GlaxoSmithKline
Sanofi
Novartis
Bayer
AstraZeneca
Eisai Co.
Takeda Pharmaceutical Company
Pharmaniaga Berhad
Duopharma Biotech Bhd
Reckitt Benckiser

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Malaysia Allergy Therapeutics Market Segmentation

By Treatment Type

Anti-allergy drugs
Immunotherapy

By Type of Allergy

Eye allergy
Asthma
Skin allergy
Food allergies
Rhinitis
Other allergy types

By Route of Administration

Oral
Inhalers
Intranasal
Other routes of administration

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies
Other distribution channel

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.